Some dynamic aspects of hematopoietic stem cells

Stem Cell Reviews

Volumn 4, Issue 1, 2008, Pages 57-64

  Dingli, David ^a   Pacheco, Jorge M ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BLOOD DISEASE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CYTOLOGY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MODELS, BIOLOGICAL;

EID: 50849143796     PISSN: 15508943     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12015-007-9007-8     Document Type: Article

References (63)

1. Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., et al. (1994). Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proceedings of the National Academy of Sciences of the United States of America, 91, 9857-9860.
2. Holyoake, T. L., Jiang, X., Drummond, M. W., Eaves, A. C., & Eaves, C. J. (2002). Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia, 16, 549-558.
3. Tefferi, A. (2003). Polycythemia vera: a comprehensive review and clinical recommendations. Mayo Clinic Proceedings, 78, 174-194.
4. McCulloch, E. A., & Till, J. E. (1964). Proliferation of hemopoietic colony-forming cells transplanted into irradiated mice. Radiation Research, 22, 383-397.
5. McCulloch, E. A., & Till, J. E. (2005). Perspectives on the properties of stem cells. Nature Medicine, 11, 1026-1028.
6. Appelbaum, F. R. (2007). Hematopoietic-cell transplantation at 50. New England Journal of Medicine, 357, 1472-1475.
7. Moore, K. A., & Lemischka, I. R. (2006). Stem cells and their niches. Science, 311, 1880-1885.
8. Scadden, D. T. (2006). The stem-cell niche as an entity of action. Nature, 441, 1075-1079.
9. Morrison, S. J., & Kimble, J. (2006). Asymmetric and symmetric stem-cell divisions in development and cancer. Nature, 441, 1068-1074.
10. Dingli, D., Traulsen, A., & Pacheco, J. M. (2007). Compartmental architecture and dynamics of hematopoiesis. PLoS ONE, 2, e345.
11. McKenzie, J. L., Gan, O. I., Doedens, M., Wang, J. C., & Dick, J. E. (2006). Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nature Immunology, 7, 1225-1233.
12. Buescher, E. S., Alling, D. W., & Gallin, J. I. (1985). Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. Journal of Clinical Investigation, 76, 1581-1584.
13. Nash, R., Storb, R., & Neiman, P. (1988). Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. Blood, 72, 2031-2037.
14. Abkowitz, J. L., Persik, M. T., Shelton, G. H., Ott, R. L., Kiklevich, J. V., et al. (1995). Behavior of hematopoietic stem cells in a large animal. Proceedings of the National Academy of Sciences of the United States of America, 92, 2031-2035.
15. Huxley, J. S. (1932). Problems of relative growth. New York, USA: Dial Press.
16. West, G. B., Brown, J. H., & Enquist, B. J. (1999). The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science, 284, 1677-1679.
17. West, G. B., & Brown, J. H. (2005). The origin of allometric scaling laws in biology from genomes to ecosystems: Towards a quantitative unifying theory of biological structure and organization. Journal of Experimental Biology, 208, 1575-1592.
18. Banavar, J. R., Maritan, A., & Rinaldo, A. (1999). Size and form in efficient transportation networks. Nature, 399, 130-132.
19. Dingli, D., & Pacheco, J. M. (2006). Allometric scaling of the active hematopoietic stem cell pool across mammals. PLoS ONE, 1, e2.
20. Spangrude, G. J., Smith, L., Uchida, N., Ikuta, K., Heimfeld, S., et al. (1991). Mouse hematopoietic stem cells. Blood, 78, 1395-1402.
21. Abkowitz, J. L., Catlin, S. N., McCallie, M. T., & Guttorp, P. (2002). Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood, 100, 2665-2667.
22. McCarthy, K. F. (1997). Population size and radiosensitivity of murine hematopoietic endogenous long-term repopulating cells. Blood, 89, 834-841.
23. McCarthy, K. F. (2003). Marrow frequency of rat long-term repopulating cells: Evidence that marrow hematopoietic stem cell concentration may be inversely proportional to species body weight. Blood, 101, 3431-3435.
24. Gordon, M. Y., Lewis, J. L., & Marley, S. B. (2002). Of mice and men...and elephants. Blood, 100, 4679-4680.
25. Dingli, D., & Pacheco, J. M. (2007). Ontogenic growth of the haemopoietic stem cell pool in humans. Proceedings of the Biological Science, 274, 2497-2501.
26. Kiel, M. J., He, S., Ashkenazi, R., Gentry, S. N., Teta, M., et al. (2007). Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU. Nature, 449, 238-242.
27. Rufer, N., Brummendorf, T. H., Kolvraa, S., Bischoff, C., Christensen, K., et al. (1999). Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. Journal of Experimental Medicine, 190, 157-167.
28. Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A. M., Sampath, J., et al. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Medicine, 7, 1028-1034.
29. Goldman, J. M. (2004). Chronic myeloid leukemia-still a few questions. Experimental Hematology, 32, 2-10.
30. Luzzatto, L., Bessler, M., & Rotoli, B. (1997). Somatic mutations in paroxysmal nocturnal hemoglobinuria: A blessing in disguise? Cell, 88, 1-4.
31. Abkowitz, J. L., Catlin, S. N., & Guttorp, P. (1996). Evidence that hematopoiesis may be a stochastic process in vivo. Nature Medicine, 2, 190-197.
32. Gordon, M. Y., & Blackett, N. M. (1994). Routes to repopulation-a unification of the stochastic model and separation of stem-cell subpopulations. Leukemia, 8, 1068-1072 discussion 1072-1063.
33. Dingli, D., Pacheco, J. M., Traulsen, A. (2007). On the coexistence of multiple mutant clones in blood. Phys Rev E Stat Nonlin Soft Matter Phys (in press).
34. Lemischka, I. R. (1997). Microenvironmental regulation of hematopoietic stem cells. Stem Cells, 15(Suppl 1), 63-68.
35. Moran, P. (1962). The statistical processes of evolutionary theory.
36. Araten, D. J., Golde, D. W., Zhang, R. H., Thaler, H. T., Gargiulo, L., et al. (2005). A quantitative measurement of the human somatic mutation rate. Cancer Research, 65, 8111-8117.
37. Dingli, D., Traulsen, A., & Pacheco, J. M. (2007). Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle, 6, 441-446.
38. Jaffe, E. S., Harris, N. L., Stein, H., Vardiman, J. W. (2001). Tumours of haematopoietic and lymphoid tissues. World Health Organization, pp 77-80.
39. Tomlinson, I., Sasieni, P., & Bodmer, W. (2002). How many mutations in a cancer? American Journal of Pathology, 160, 755-758.
40. Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzle, K. W., & Velculescu, V. E. (2007). Genetic progression and the waiting time to cancer. PLoS Computational Biology, 3, e225.
41. Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., et al. (1998). Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood, 92, 3780-3792.
42. Koschmieder, S., Gottgens, B., Zhang, P., Iwasaki-Arai, J., Akashi, K., et al. (2005). Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood, 105, 324-334.
43. Michor, F., Iwasa, Y., & Nowak, M. A. (2006). The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proceedings of the National Academy of Sciences of the United States of America, 103, 14931-14934.
44. Lange, B. (2000). The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. British Journal of Haematology, 110, 512-524.
45. Massey, G. V., Zipursky, A., Chang, M. N., Doyle, J. J., Nasim, S., et al. (2006). A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood, 107, 4606-4613.
46. Zipursky, A., Brown, E. J., Christensen, H., & Doyle, J. (1999). Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clinics in Laboratory Medicine, 19, 157-167 vii).
47. Tricot, G., Mecucci, C., & Van den Berghe, H. (1986). Evolution of the myelodysplastic syndromes. British Journal of Haematology, 63, 609-614.
48. Gale, R. E., Allen, A. J., Nash, M. J., & Linch, D. C. (2006). Long-term serial analysis of X-chromosome inactivation patterns and JAK2 V617F mutant levels in patients with essential thrombocythemia show that minor mutant-positive clones can remain stable for many years. Blood, 109, 1241-1243.
49. Yatabe, Y., Tavare, S., & Shibata, D. (2001). Investigating stem cells in human colon by using methylation patterns. Proceedings of the National Academy of Sciences of the United States of America, 98, 10839-10844.
50. Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., et al. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423, 409-414.
51. Reya, T. (2003). Regulation of hematopoietic stem cell self-renewal. Recent Progress in Hormone Research, 58, 283-295.
52. Reya, T., & Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature, 434, 843-850.
53. Albertson, R., & Doe, C. Q. (2003). Dlg, Scrib and Lgl regulate neuroblast cell size and mitotic spindle asymmetry. Nature Cell Biology, 5, 166-170.
54. Lee, C. Y., Robinson, K. J., & Doe, C. Q. (2006). Lgl, Pins and aPKC regulate neuroblast self-renewal versus differentiation. Nature, 439, 594-598.
55. Dingli, D., Traulsen, A., & Michor, F. (2007). (A)symmetric stem cell replication and cancer. PLoS Comput Biol, 3, e53.
56. Jamieson, C. H., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., et al. (2004). Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. New England Journal of Medicine, 351, 657-667.
57. Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., et al. (2006). Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature, 442, 818-822.
58. Traulsen, A., Pacheco, J. M., & Dingli, D. (2007). On the origin of multiple mutant clones in paroxysmal nocturnal hemoglobinuria. Stem Cells, 25, 3081-3084.
59. Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111.
60. Schmidt-Nielsen, K. (1984). Why is animal size so important?. New York, USA: Cambridge University Press.
61. Lopes, J. V., Pacheco, J. M., Dingli, D. (2007). Acquired hematopoietic stem cell disorders and mammalian size. Blood, 110, 4120-4122.
62. Kunkel, T. A., & Bebenek, K. (2000). DNA replication fidelity. Annual Reviews of Biochemistry, 69, 497-529.
63. Squire, R. A. (1969). Spontaneous hematopoietic tumors in dogs. National Cancer Institute Monographs, 32, 97-116.